BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 7.22% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 6.74% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 5.16% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.36% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 3.70% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.54% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 3.49% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 3.27% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.27% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 3.22% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.11% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.05% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| AZN_old | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 2.68% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.67% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.51% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.43% |
| TEM | Tempus AI, Inc. Class A Common Stock | Healthcare | Health Information Services | 2.40% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 2.35% |